274 related articles for article (PubMed ID: 19182564)
1. Results of the STAR*D study: implications for clinicians and drug developers.
Preskorn SH
J Psychiatr Pract; 2009 Jan; 15(1):45-9. PubMed ID: 19182564
[No Abstract] [Full Text] [Related]
2. STAR*D: a summary and UK perspective.
Deakin J; O'Loughlin C
J Psychopharmacol; 2009 Aug; 23(6):605-12. PubMed ID: 19395428
[No Abstract] [Full Text] [Related]
3. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
4. Introduction: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():3-4. PubMed ID: 22951235
[No Abstract] [Full Text] [Related]
5. Treatment of the cardiac-impaired depressed patient. Part I: General considerations, heterocyclic antidepressants, and monoamine oxidase inhibitors.
Goldstein MG; Guttmacher LB
Psychiatr Med; 1988; 6(3):1-33. PubMed ID: 3062672
[No Abstract] [Full Text] [Related]
6. Use of antidepressants.
Tamburrino M; Johnson LW
Am Fam Physician; 1987 Sep; 36(3):236-42. PubMed ID: 3630886
[No Abstract] [Full Text] [Related]
7. Monoamine oxidase inhibitors revisited: what you should know.
Goldberg JF; Thase ME
J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
[No Abstract] [Full Text] [Related]
8. Depression in medical illness. Workshop report.
Paykel E
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):205-7. PubMed ID: 8468445
[No Abstract] [Full Text] [Related]
9. History of antidepressants: successes and failures.
Kelwala S; Stanley M; Gershon S
J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
[No Abstract] [Full Text] [Related]
10. Pharmacology of antidepressants in use in the United States.
Richelson E
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):4-13. PubMed ID: 7174631
[No Abstract] [Full Text] [Related]
11. Atypical depression. A valid clinical entity?
Stewart JW; McGrath PJ; Rabkin JG; Quitkin FM
Psychiatr Clin North Am; 1993 Sep; 16(3):479-95. PubMed ID: 8415233
[TBL] [Abstract][Full Text] [Related]
12. Endogenous depression: biochemical determinants and drug treatment.
Hollister LE
Drug Ther; 1982; ():81-98. PubMed ID: 7049653
[No Abstract] [Full Text] [Related]
13. Cardiovascular effects of antidepressants.
Cassem N
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):22-9. PubMed ID: 6816788
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants of the future.
Priest RG
Br J Psychiatry Suppl; 1989 Oct; (6):7-8. PubMed ID: 2619975
[No Abstract] [Full Text] [Related]
15. Cardiac effects of antidepressants.
Donlon PT
Geriatrics; 1982 Apr; 37(4):53-60. PubMed ID: 6800888
[TBL] [Abstract][Full Text] [Related]
16. [Psychotropic drugs in internal medicine. I. Antidepressants].
de la Fuente JR
Rev Invest Clin; 1983; 35(3):247-56. PubMed ID: 6415779
[No Abstract] [Full Text] [Related]
17. Revitalizing monoamine oxidase inhibitors: a call for action.
Gillman PK; Feinberg SS; Fochtmann LJ
CNS Spectr; 2020 Aug; 25(4):452-454. PubMed ID: 31272520
[No Abstract] [Full Text] [Related]
18. [Treatment of depressive disorders].
Saiz Ruiz J; Ibáñez Cuadrado A
Rev Clin Esp; 1997 Nov; 197 Suppl 3():35-43. PubMed ID: 9477689
[No Abstract] [Full Text] [Related]
19. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
Cassidy F
Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
[No Abstract] [Full Text] [Related]
20. [Clinical studies: the missing antidepressants].
Faludi G
Neuropsychopharmacol Hung; 2005 Sep; 7(3):103-4. PubMed ID: 16493873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
